Search
-
Ipsos Update – December 2024
Security, Inflation, Perils of Perception … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
-
Pure Protein: Powering Up Beyond the Gym
Ipsos research shows how a protein bar brand can transcend its niche image by tapping into the power of context and empathy, showcasing its versatility and appeal within the context of everyday snacking occasions.
-
2024 holiday shopping data may signal longer-term shifts in consumer behavior
Why this holiday season may be a bellwether for changes in holiday shopping beyond just November and December.
-
Ipsos survey reveals gap between Veterans' needs and public perceptions
Survey results also suggest an opportunity to educate further regarding particular benefits available to Veterans and their caregivers
-
How GLP-1s create opportunities for brands and retailers to address new self-care needs
CPG companies and retailers can act as trusted advisors and provide valuable advice and information, such as diet plans, exercise regimens, and ways to manage medication side effects. Here’s where to start.
-
One in four say they plan to set up a will soon
One in four Americans say they will set up a will or a trust soon, according to new data from the Ipsos Consumer Tracker.
-
Ipsos Update - November 2024
Mental Health, AI, Infrastructure … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
-
John Boerstler joins Ipsos Public Affairs as Executive Vice President with a focus on public sector
Boerstler brings a wealth of experience and a strong network within government and public sector organizations.
-
Reshaping Society: Insights to Activate
GLP-1s have the potential to make a massive impact on the global economy. Stakeholders in various industries must adapt, and proactively, to stay ahead of the curve. Here’s how.
-
Many insured Americans experience delays and denial of care because of health insurance
The latest Patient Experience Survey from PhRMA/Ipsos finds most support policies lowering out-of-pocket costs